Patent · US Active

Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate

US8551957B2 · kind B2 · utility

32Cited by

60References

48Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Klaus Dugi · Dresden, DE
Michael Mark · Biberach an der Riß, DE
Leo Thomas · Biberach, DE
Frank Himmelsbach · Mittelbiberach, DE

Key dates

Filing date	Aug 15, 2008
Grant date	Oct 8, 2013
Priority date	—
Expiry date	Apr 2, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a pharmaceutical composition according to the claim 1 comprising a glucopyranosyl-substituted benzene derivative in combination with a DPP IV inhibitor which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.